by Alexander Fenkiw | Oct 18, 2024 | medical-software-whitepaper
Are there still software medical devices in risk class I according to MDR? Are risk class I software products really being withdrawn from the market by regulatory authorities? Which federal state do I have to go to so that I can remain on the market with my class I...
by Alexander Fenkiw | Sep 18, 2024 | Unkategorisiert
On December 19, 2019, the Digital Supply Act (DVG) made it possible for doctors to be able to prescribe digital health applications (DiGA) to patients in a standardized way for the first time. Now a counterpart has also been created for nursing care: digital care apps...
by Alexander Fenkiw | Sep 11, 2024 | medical-software-whitepaper
The EU is now also regulating the use of artificial intelligence (AI) with the EU AI Act. This also affects manufacturers of software medical devices that integrate AI into their MDR medical devices. The AI Act is intended to ensure that AI systems are designed in a...
by Alexander Fenkiw | Sep 10, 2024 | DiGA
Digital health applications (DiGA) will soon require certificates for data security and data protection. However, the original deadlines for this were set somewhat too optimistically, which is why they have now been postponed to the future by the Hospital Nursing...
by Alexander Fenkiw | Sep 10, 2024 | medical-software-whitepaper
How do I actually decide whether my product is a medical device? Where do I start when I want to determine its risk class? And what statements can I use to promote my product in the end? The answers to these and many other questions can be answered on the basis of...